- Home
- TIPT vs MDXG Comparison
TIPT vs MDXG Comparison
Compare TIPT & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIPT
- MDXG
- Stock Information
- Founded
- TIPT 2007
- MDXG 2006
- Country
- TIPT United States
- MDXG United States
- Employees
- TIPT N/A
- MDXG N/A
- Industry
- TIPT Property-Casualty Insurers
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- TIPT Finance
- MDXG Health Care
- Exchange
- TIPT Nasdaq
- MDXG Nasdaq
- Market Cap
- TIPT 881.3M
- MDXG 1.1B
- IPO Year
- TIPT 2007
- MDXG N/A
- Fundamental
- Price
- TIPT $22.64
- MDXG $7.14
- Analyst Decision
- TIPT
- MDXG Buy
- Analyst Count
- TIPT 0
- MDXG 1
- Target Price
- TIPT N/A
- MDXG $12.00
- AVG Volume (30 Days)
- TIPT 126.5K
- MDXG 466.3K
- Earning Date
- TIPT 10-29-2025
- MDXG 10-29-2025
- Dividend Yield
- TIPT 1.06%
- MDXG N/A
- EPS Growth
- TIPT 74.19
- MDXG N/A
- EPS
- TIPT 1.29
- MDXG 0.21
- Revenue
- TIPT $2,024,136,000.00
- MDXG $363,774,000.00
- Revenue This Year
- TIPT N/A
- MDXG $12.68
- Revenue Next Year
- TIPT N/A
- MDXG $8.18
- P/E Ratio
- TIPT $18.13
- MDXG $33.98
- Revenue Growth
- TIPT 6.10
- MDXG 6.85
- 52 Week Low
- TIPT $18.25
- MDXG $5.47
- 52 Week High
- TIPT $26.90
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- TIPT 49.97
- MDXG 53.02
- Support Level
- TIPT $22.99
- MDXG $6.98
- Resistance Level
- TIPT $23.51
- MDXG $7.23
- Average True Range (ATR)
- TIPT 0.67
- MDXG 0.18
- MACD
- TIPT -0.02
- MDXG -0.03
- Stochastic Oscillator
- TIPT 36.95
- MDXG 39.02
About TIPT Tiptree Inc.
Tiptree Inc is a United States-based company that provides specialty insurance products and related services. It has two reportable segments: Insurance and Mortgage. The company generates the majority of its revenue from the Insurance Segment, which is engaged in designing, marketing, and underwriting specialty property and casualty insurance products incorporating value-added coverages and services for select target markets or niches. The Mortgage segment originates loans for sale to institutional investors, including GSEs and FHA/VA, and services loans on behalf of Fannie Mae, Freddie Mac, and Ginnie Mae.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.